Gilead had its moment with the covid antiviral, below. Now, trade them on T2BF.via ychartsAbbVie rose ~30% in the first half of the year.But investors want gains quickly. $MRNA Moderna is leading the charge. As the vaccine rolls out in the next 90 days, ABBV and GILD will slump further. Both are buys.Time the entry price right in both.Add all three stocks to your T2BF right now.